Literature DB >> 707736

The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck.

R M Byers, K I Bland, B Borlase, M Luna.   

Abstract

The records of 216 patients with squamous cell carcinoma of the oral cavity, oropharynx, and hypopharynx treated by surgery alone were reviewed. Frozen section control at the time of the surgical procedure was used to evaluate the margins of the excision. Findings at frozen section were correlated with local control and survival. The inability of the surgeon to obtain clear margins by frozen section for whatever reason resulted in a very high incidence of local recurrence and death. The fact that the patient's tumor could be removed with free margins at the time of surgery did not guarantee long-term success, although the frozen section technic did prove to be reliable and an effective tool for evaluating the patient's prognosis and the efficacy of the surgical procedure.

Entities:  

Mesh:

Year:  1978        PMID: 707736     DOI: 10.1016/0002-9610(78)90275-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  23 in total

Review 1.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

2.  Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract.

Authors:  Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2008-07-15

3.  Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.

Authors:  Marisa R Buchakjian; Timothy Ginader; Kendall K Tasche; Nitin A Pagedar; Brian J Smith; Steven M Sperry
Journal:  Otolaryngol Head Neck Surg       Date:  2018-05-08       Impact factor: 3.497

Review 4.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

5.  Prognostic value of frozen section in t1, t2 carcinoma of oral cavity.

Authors:  Sandhya Gokavarapu; L M Chandrasekhara Rao; Sujit Chau Patnaik; Nagendra Parvataneni; K V V N Raju; Ravi Chander
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-10-21

6.  Definition of "Close Margin" in Oral Cancer Surgery and Association of Margin Distance With Local Recurrence Rate.

Authors:  Kendall K Tasche; Marisa R Buchakjian; Nitin A Pagedar; Steven M Sperry
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

Review 7.  Surgical margins in head and neck squamous cell carcinoma: what is 'close'?

Authors:  Matteo Alicandri-Ciufelli; Marco Bonali; Alessia Piccinini; Laura Marra; Angelo Ghidini; Elio Maria Cunsolo; Antonino Maiorana; Livio Presutti; Pier Franco Conte
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-28       Impact factor: 2.503

8.  Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.

Authors:  Lindsay S Moore; Eben L Rosenthal; Thomas K Chung; Esther de Boer; Neel Patel; Andrew C Prince; Melissa L Korb; Erika M Walsh; E Scott Young; Todd M Stevens; Kirk P Withrow; Anthony B Morlandt; Joshua S Richman; William R Carroll; Kurt R Zinn; Jason M Warram
Journal:  J Nucl Med       Date:  2016-09-01       Impact factor: 10.057

9.  Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.

Authors:  Parul Sinha; Mitra Mehrad; Rebecca D Chernock; James S Lewis; Samir K El-Mofty; Ningying Wu; Brian Nussenbaum; Bruce H Haughey
Journal:  Head Neck       Date:  2014-01-16       Impact factor: 3.147

10.  Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I.

Authors:  Antonia Kolokythas
Journal:  J Oral Maxillofac Res       Date:  2010-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.